Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis

Dimethyl fumarate (DMF) is a first-line prodrug for the treatment of relapsing-remitting multiple sclerosis (RRMS) that is completely metabolized to monomethyl fumarate (MMF), the active metabolite, before reaching the systemic circulation. Its metabolism has been proposed to be due to ubiquitous esterases in the intestines and other tissues, but the specific enzymes involved are unknown. We hypothesized based on its structure and extensive presystemic metabolism that DMF would be a carboxylesterase substrate subject to interaction with alcohol. We sought to determine the enzymes(s) responsible for the extensive presystemic metabolism of DMF to MMF and the effect of alcohol on its disposition by conducting metabolic incubation studies in human recombinant carboxylesterase-1 (CES1), carboxylesterase-2 (CES2) and human intestinal microsomes (HIM), and by performing a follow-up study in an in vivo mouse model. The in vitro incubation studies demonstrated that DMF was only metabolized to MMF by CES1. Consistent with the incubation studies, the mouse pharmacokinetic study demonstrated that alcohol decreased the maximum concentration and area-under-the-curve of MMF in the plasma and the brain after dosing with DMF. We conclude that alcohol may markedly decrease exposure to the active MMF metabolite in the plasma and brain potentially decreasing the effectiveness of DMF in the treatment of RRMS.

[1]  C. Andrade,et al.  Neuroprotective effects of dimethyl fumarate against depression-like behaviors via astrocytes and microglia modulation in mice: possible involvement of the HCAR2/Nrf2 signaling pathway , 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  D. Ouyang,et al.  Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation. , 2022, International immunopharmacology.

[3]  A. Dattola,et al.  The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway , 2022, Frontiers in Medicine.

[4]  P. Potter,et al.  Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition , 2020, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  Lucy Her,et al.  Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators , 2019, Drug Metabolism and Disposition.

[6]  D. Dubey,et al.  Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence , 2019, Patient preference and adherence.

[7]  H. Ullum,et al.  Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort , 2018, Multiple sclerosis.

[8]  A. Filla,et al.  Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans , 2017, Human molecular genetics.

[9]  Hermes Licea-Perez,et al.  LC-MS/MS quantification of dimethyl fumarate and methyl hydrogen fumarate in rat blood using tiopronin as trapping reagent , 2016 .

[10]  A. D. De Livera,et al.  Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study , 2016, PloS one.

[11]  B. Meibohm,et al.  Effects of Alcohol on Human Carboxylesterase Drug Metabolism , 2015, Clinical Pharmacokinetics.

[12]  T. Olsson,et al.  Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. , 2014, JAMA neurology.

[13]  J. Markowitz,et al.  Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation , 2013, European Journal of Clinical Pharmacology.

[14]  V. Herring,et al.  The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? , 2013, Pharmacotherapy.

[15]  Daryl R. Kipke,et al.  Whole Animal Perfusion Fixation for Rodents , 2012, Journal of visualized experiments : JoVE.

[16]  K. Patrick,et al.  Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. , 2011, Journal of pharmaceutical sciences.

[17]  P. Jacob,et al.  Cocaethylene formation following ethanol and cocaine administration by different routes. , 2011, Experimental and clinical psychopharmacology.

[18]  U. Mrowietz,et al.  Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients , 2010, Archives of Dermatological Research.

[19]  J. Bauman,et al.  Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  Julie A. Johnson,et al.  Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. , 2008, American journal of human genetics.

[21]  A. Straughn,et al.  Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and Pharmacodynamics , 2007, Clinical pharmacology and therapeutics.

[22]  Jian Yang,et al.  Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol , 2006, Journal of Pharmacology and Experimental Therapeutics.

[23]  Teruko Imai,et al.  Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.

[24]  P. Taylor,et al.  Current progress on esterases: from molecular structure to function. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[25]  M. Wierdl,et al.  Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase. , 2000, Cancer research.

[26]  J. Lima,et al.  Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[27]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.